Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00160303 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow
A Phase 3 study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
NCT00160303: Completed Phase 3 study, sponsored by Spaulding Rehabilitation Hospital.
NCT00160303 is a Phase 3 study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 56 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00160303, a Phase 3 study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of the research is to study the effects of two different injection therapies for the treatment of lateral epicondylitis (tennis elbow). Specifically, we will look at which therapy provides better short and long-term relief of pain, which treatment allows better function and less disability, and which treatment gives back better strength in the affected hand. Each subject will receive only one of the two treatments. Although both of these treatments are usually very well tolerated, it is important to make this comparison because it is believed that one of these therapies may have better long term effectiveness, with a lower cost, and smaller number of potential side effects.
Interventions
- DRUG Prolotherapy
- DRUG Local Corticosteroid Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
What the finished NCT00160303 record still lists
NCT00160303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Prolotherapy is the first listed.
NCT00160303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00160303 about?
NCT00160303 is a clinical study titled "Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow". The purpose of the research is to study the effects of two different injection therapies for the treatment of lateral epicondylitis (tennis elbow). Specifically, we will look at which therapy provides better short and long-term relief of pain, which treatment allows better function and less disabili...
What is the current status of trial NCT00160303?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants. The study started on 2005-01. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00160303?
The interventions under investigation include: Prolotherapy (DRUG), Local Corticosteroid Therapy (DRUG).
Who is sponsoring clinical trial NCT00160303?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00160303's enrollment target sits among peer trials
56 1827th of 2000 higher than 167 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia